Al-Rasheed University College
Baghdad, AL-Adhmia, 12221, Iraq
NCT Number: NCT04477421
Comparison of femtosecond small incision lenticule extraction (FS-SMILE) versus Femtosecond laser Insitu Keratomileusis (FS-LASIK) regarding dry eye disease (DED) and corneal sensitivity (CS) after those refractive surgeries.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Baghdad, AL-Adhmia, 12221, Iraq
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Femtosecond small incision lenticule extraction
Femtosecond laser Insitu keratomileusis
Time frame: After 1 month of surgery
Ocular Surface Disease Index (the index range from 0 to 100), higher value indicate more severe disease
Time frame: After 6 months of surgery
Ocular Surface Disease Index (the index range from 0 to 100), higher value indicate more severe disease
Time frame: After 1 month of surgery
Tear Break-Up Time (in seconds)
Time frame: After 6 months of surgery
Tear Break-Up Time (in seconds)
Time frame: After 1 month of surgery
Schirmer I test (in mm/5 minutes)
Time frame: After 6 months of surgery
Schirmer I test (in mm/5 minutes)
Time frame: After 1 month of surgery
Oxford score (the score range from 0 to 5), higher value indicate more severe disease
Time frame: After 6 months of surgery
Oxford score (the score range from 0 to 5), higher value indicate more severe disease
Time frame: After 1 month of surgery
Dry Eye Work Shop scale (value range from 0 to 4), higher value indicate more severe disease
Time frame: After 6 months of surgery
Dry Eye Work Shop scale (value range from 0 to 4), higher value indicate more severe disease
Al-Rasheed University College
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07238699
Dry Eye Disease, Dry Eye Syndromes
Sydney, New South Wales, Australia
View Trial DetailsNCT07025811
Dry Eye Disease, Dry Eye Syndromes
Newport Beach, California, United States
View Trial DetailsNCT07128628
Dry Eye Disease, Dry Eye Syndromes
Phoenix, Arizona, United States
View Trial DetailsNCT07264517
Autoimmune Diseases, Dry Eye Disease
Glendale, California, United States
View Trial Details